Clinical Trials on Moderate to Severe Papulopustular Rosacea
Total 644 results
-
Actavis Inc.CompletedModerate to Severe Papulopustular RosaceaUnited States
-
BioPharmX, Inc.CompletedModerate to Severe Papulopustular RosaceaUnited States
-
Galderma R&DCompleted
-
AiViva BioPharma, Inc.Withdrawn
-
Sol-Gel Technologies, Ltd.TerminatedPapulopustular RosaceaUnited States
-
Sol-Gel Technologies, Ltd.Completed
-
Hovione Scientia LimitedCompletedRosacea | Papulopustular RosaceaUnited States
-
Alfasigma S.p.A.UnknownPapulopustular RosaceaItaly
-
Beer, Kenneth R., M.D., PAMedicis Pharmaceutical CorporationCompletedMild to Moderate Temporal Atrophy | Moderate to Severe Glabellar Rhytids | Moderate to Severe Periorbital RhytidsUnited States
-
Vyne Therapeutics Inc.Premier Research Group plcCompletedFacial Papulopustular RosaceaUnited States
-
Vyne Therapeutics Inc.Premier Research Group plcCompletedFacial Papulopustular RosaceaUnited States
-
Amorepacific CorporationCompletedPapulopustular Rosacea | Erythematotelangiectatic RosaceaKorea, Republic of
-
bioRASI, LLCCompletedPapulopustular Rosacea | Erythematotelangiectatic RosaceaUnited States
-
Aqpha Medical B.V.Not yet recruitingModerate to Severe Nasolabial Fold
-
Daewoong Pharmaceutical Co. LTD.Completed
-
Galderma R&DCompletedModerate to Severe Glabellar LinesChina
-
EuBiologics Co.,LtdCompletedModerate to Severe Glabellar LinesKorea, Republic of
-
AllerganCompletedModerate to Severe Nasolabial FoldsGermany, Netherlands
-
IpsenCompletedModerate to Severe Glabellar LinesFrance, Germany
-
Daewoong Pharmaceutical Co. LTD.CompletedModerate to Severe Glabellar LineKorea, Republic of
-
JHM BioPharma (Tonghua) Co. , Ltd.Recruiting
-
AbbVieCompletedModerate to Severe Glabellar LinesJapan
-
Chongqing Claruvis Pharmaceutical Co., Ltd.CompletedModerate to Severe Glabellar LinesChina
-
Croma-Pharma GmbHCompleted
-
AllerganCompletedModerate to Severe Nasolabial FoldsUnited States
-
Azitra Inc.SuspendedPapulopustular Rosacea | Epidermal Growth FactorUnited States
-
Bionou Research, S.L.RecruitingRosacea | Rosacea, Papulopustular | Rosacea Papular TypeSpain
-
Alfasigma S.p.A.bioRASI, LLCCompletedPapulopustular RosaceaUnited States
-
Journey Medical CorporationDr. Reddy's Laboratories LimitedCompletedPapulopustular RosaceaUnited States, Germany
-
Tarsus Pharmaceuticals, Inc.Active, not recruiting
-
LEO PharmaBayerCompletedPapulopustular RosaceaUnited States
-
LEO PharmaBayerCompletedPapulopustular RosaceaGermany
-
Galderma R&DCompletedPapulopustular RosaceaUnited States
-
Galderma R&DCompleted
-
LEO PharmaBayerCompleted
-
Anne ChangCompletedPapulopustular RosaceaUnited States
-
Clinical Research Center of the CarolinasBayerCompletedRosacea, PapulopustularUnited States
-
Maruho Co., Ltd.Completed
-
Journey Medical CorporationDr. Reddy's Laboratories LimitedCompletedPapulopustular RosaceaUnited States
-
George Washington UniversityDUSA Pharmaceuticals, Inc.Completed
-
Sol-Gel Technologies, Ltd.Completed
-
LEO PharmaBayerCompletedPapulopustular RosaceaUnited States
-
LEO PharmaBayerCompletedPapulopustular RosaceaUnited States
-
BioPharmX, Inc.UnknownPapulopustular RosaceaUnited States
-
Vyne Therapeutics Inc.CompletedRosacea | Papulopustular RosaceaGermany
-
Galderma R&DCompletedPapulopustular RosaceaFrance, United Kingdom, Hungary, Germany, Bulgaria, Czech Republic, Poland, Romania, Russian Federation, Ukraine
-
Maruho Co., Ltd.Completed
-
Merz North America, Inc.CompletedModerate to Severe Midface Volume DeficitCanada
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Canada
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States